152 related articles for article (PubMed ID: 27871888)
1. Multidrug and toxin extrusion proteins mediate cellular transport of cadmium.
Yang H; Guo D; Obianom ON; Su T; Polli JE; Shu Y
Toxicol Appl Pharmacol; 2017 Jan; 314():55-62. PubMed ID: 27871888
[TBL] [Abstract][Full Text] [Related]
2. Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters.
Tanihara Y; Masuda S; Sato T; Katsura T; Ogawa O; Inui K
Biochem Pharmacol; 2007 Jul; 74(2):359-71. PubMed ID: 17509534
[TBL] [Abstract][Full Text] [Related]
3. Urinary Dopamine as a Potential Index of the Transport Activity of Multidrug and Toxin Extrusion in the Kidney.
Kajiwara M; Ban T; Matsubara K; Nakanishi Y; Masuda S
Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483254
[TBL] [Abstract][Full Text] [Related]
4. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
Müller F; König J; Hoier E; Mandery K; Fromm MF
Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
[TBL] [Abstract][Full Text] [Related]
5. Impact of Substrate-Dependent Inhibition on Renal Organic Cation Transporters hOCT2 and hMATE1/2-K-Mediated Drug Transport and Intracellular Accumulation.
Yin J; Duan H; Wang J
J Pharmacol Exp Ther; 2016 Dec; 359(3):401-410. PubMed ID: 27758931
[TBL] [Abstract][Full Text] [Related]
6. Renal tubular secretion of varenicline by multidrug and toxin extrusion (MATE) transporters.
Kajiwara M; Masuda S; Watanabe S; Terada T; Katsura T; Inui K
Drug Metab Pharmacokinet; 2012; 27(6):563-9. PubMed ID: 22510868
[TBL] [Abstract][Full Text] [Related]
7. Functional characteristics of two human MATE transporters: kinetics of cimetidine transport and profiles of inhibition by various compounds.
Ohta KY; Inoue K; Yasujima T; Ishimaru M; Yuasa H
J Pharm Pharm Sci; 2009; 12(3):388-96. PubMed ID: 20067714
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Renal Efflux Transporter MATE1 in Renal Excretion of Flecainide.
Doki K; Apáti S; Sakata T; Homma M
Biol Pharm Bull; 2019; 42(7):1226-1229. PubMed ID: 31257298
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family).
Yonezawa A; Masuda S; Yokoo S; Katsura T; Inui K
J Pharmacol Exp Ther; 2006 Nov; 319(2):879-86. PubMed ID: 16914559
[TBL] [Abstract][Full Text] [Related]
10. Contribution of MATE1 to Renal Secretion of the NMDA Receptor Antagonist Memantine.
Müller F; Weitz D; Derdau V; Sandvoss M; Mertsch K; König J; Fromm MF
Mol Pharm; 2017 Sep; 14(9):2991-2998. PubMed ID: 28708400
[TBL] [Abstract][Full Text] [Related]
11. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).
Li Q; Guo D; Dong Z; Zhang W; Zhang L; Huang SM; Polli JE; Shu Y
Toxicol Appl Pharmacol; 2013 Nov; 273(1):100-9. PubMed ID: 24001450
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 4',6-diamidino-2-phenylindole as a fluorescent probe substrate for rapid assays of the functionality of human multidrug and toxin extrusion proteins.
Yasujima T; Ohta KY; Inoue K; Ishimaru M; Yuasa H
Drug Metab Dispos; 2010 Apr; 38(4):715-21. PubMed ID: 20047987
[TBL] [Abstract][Full Text] [Related]
13. Atenolol Renal Secretion Is Mediated by Human Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Proteins.
Yin J; Duan H; Shirasaka Y; Prasad B; Wang J
Drug Metab Dispos; 2015 Dec; 43(12):1872-81. PubMed ID: 26374172
[TBL] [Abstract][Full Text] [Related]
14. Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine.
Ito S; Kusuhara H; Kuroiwa Y; Wu C; Moriyama Y; Inoue K; Kondo T; Yuasa H; Nakayama H; Horita S; Sugiyama Y
J Pharmacol Exp Ther; 2010 Apr; 333(1):341-50. PubMed ID: 20065018
[TBL] [Abstract][Full Text] [Related]
15. Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate).
Ceckova M; Reznicek J; Deutsch B; Fromm MF; Staud F
PLoS One; 2018; 13(8):e0202706. PubMed ID: 30114293
[TBL] [Abstract][Full Text] [Related]
16. Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells.
Tsuda M; Terada T; Ueba M; Sato T; Masuda S; Katsura T; Inui K
J Pharmacol Exp Ther; 2009 Apr; 329(1):185-91. PubMed ID: 19164462
[TBL] [Abstract][Full Text] [Related]
17. Fampridine is a Substrate and Inhibitor of Human OCT2, but not of Human MATE1, or MATE2K.
Xiao G; Rowbottom C; Boiselle C; Gan LS
Pharm Res; 2018 Jun; 35(8):159. PubMed ID: 29915999
[TBL] [Abstract][Full Text] [Related]
18. Divergent Regulation of OCT and MATE Drug Transporters by Cadmium Exposure.
Yang H; Zhou S; Guo D; Obianom ON; Li Q; Shu Y
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33924306
[TBL] [Abstract][Full Text] [Related]
19. Selective Inhibition on Organic Cation Transporters by Carvedilol Protects Mice from Cisplatin-Induced Nephrotoxicity.
Guo D; Yang H; Li Q; Bae HJ; Obianom O; Zeng S; Su T; Polli JE; Shu Y
Pharm Res; 2018 Sep; 35(11):204. PubMed ID: 30191328
[TBL] [Abstract][Full Text] [Related]
20. Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2.
Masuda S; Terada T; Yonezawa A; Tanihara Y; Kishimoto K; Katsura T; Ogawa O; Inui K
J Am Soc Nephrol; 2006 Aug; 17(8):2127-35. PubMed ID: 16807400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
